SCHEMBL3102156

SCHEMBL3102156

COc1ccc(C(=O)CC(O)Cc2ccc(OCCN(C)C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
ALDH1A1 P00352 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
DRD2 P14416 3/20 0.48
DRD3 P35462 2/20 0.48
HRH3 Q9Y5N1 2/20 0.48
ACHE P22303 3/20 0.46
LMNA P02545 1/20 0.46
SLC6A2 P23975 1/20 0.46
CYP2C19 P33261 1/20 0.46
KCNH2 Q12809 1/20 0.46
THRA P10827 2/20 0.45
THRB P10828 1/20 0.45
MAPK1 P28482 1/20 0.45
BCHE P06276 2/20 0.45
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
POLB P06746 1/20 0.44
ESRRB O95718 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3105574 0.86 LDHA (0.56) MAPTLMNAPOLB
SCHEMBL10677214 0.82 ALDH1A1 (0.64) SMN1; SMN2ALDH1A1GAAMAPTDRD2
SCHEMBL3696404 0.80 HRH3 (0.57) SMN1; SMN2ALDH1A1GAAHRH3KCNH2
SCHEMBL3105307 0.80 HPGD (0.54) ALDH1A1GAAMAPTKCNH2POLB
SCHEMBL3085006 0.80 LDHA (0.49) SMN1; SMN2ALDH1A1GAAMAPTLMNA
SCHEMBL3102314 0.79 NPC1 (0.61) SMN1; SMN2ALDH1A1MAPTACHE
SCHEMBL3102764 0.75 LMNA (0.71) SMN1; SMN2ALDH1A1GAAMAPTACHE
SCHEMBL7598204 0.73 THRA (0.62) SMN1; SMN2ALDH1A1GAAMAPTDRD2
Hydrochloric Acid SCHEMBL21595634 0.72 SMN1; SMN2 (0.68) SMN1; SMN2ALDH1A1GAAHRH3KCNH2
SCHEMBL631740 0.72 THRA (0.57) ALDH1A1MAPTDRD2DRD3HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249243-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY PULKKINEN JUHA 2010-09-30 US disclosed
US-20100249243-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY PULKKINEN JUHA 2010-09-30 US disclosed
WO-2009066008-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY PULKKINEN JUHA (FI) 2009-05-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249243-A1 NOVEL BETA-HYDROXYKETONES AND BETA-ALKOXYKETONES WITH ESTROGENIC ACTIVITY HSD17B11, HSD17B7, CYP19A1 SMN1; SMN2 4873/4885ALDH1A1 577/4885GAA 1359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.